Page last updated: 2024-11-02

oxidopamine and Immunologic Deficiency Syndromes

oxidopamine has been researched along with Immunologic Deficiency Syndromes in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Ariki, S1
Husband, AJ1
Hall, NR1
O'Grady, MP1
Menzies, RA1

Reviews

1 review available for oxidopamine and Immunologic Deficiency Syndromes

ArticleYear
Neuroimmunopharmacologic effects of drugs of abuse.
    Advances in experimental medicine and biology, 1991, Volume: 288

    Topics: Animals; Autonomic Nervous System; Brain Chemistry; Catecholamines; Complement System Proteins; Huma

1991

Other Studies

1 other study available for oxidopamine and Immunologic Deficiency Syndromes

ArticleYear
Sympathectomy abrogates immunodeficiency associated with protein-energy malnutrition.
    Journal of neuroimmunology, 1999, Sep-01, Volume: 99, Issue:1

    Topics: Animals; Female; Immunoglobulin A; Immunologic Deficiency Syndromes; Injections, Intraperitoneal; In

1999